SNAAT vs PCR
How Genomtec ID works?
GENOMTEC is the winner of the Next Health Investment Pitch competition organized by Amgen and ImpactCEE
Operational Program: Intelligent Development 2014-2020 - "Fast Track"
European Congress of Clinical Microbiology & Infectious Diseases
Victory at the Start-Up-Med
We are back to the European Startup Days
Genomtec is the owner of the European Union’s trademarks: GENOMTEC™ and SNAAT™
We are pleased to announce that the EUIPO (European Union Intellectual Property Office) granted to Genomtec the rights to the European ...
Genomtec ID announces a breakthrough in MOBILE diagnostics
There is a lot of talk these days about mobility of diagnostic devices which would allow for tests at the patient’s location. Such tests ...
Master and apprentice in a startup: “MamStartup” about Genomtec
Startups are the fruit of youth and a fresh approach to business. Who thinks so? Raise your hand! I’m only halfway in. Of course, being ...
R&D expert, Miron Tokarski talks about the proprietary SNAAT technology in the Polish Radio’s “Science Station” programme
Feel invited to listen to the Polish Radio’s “Science Station” programme featuring Miron Tokarski, an R&D Department expert, ...
“A diagnosis in less than twenty minutes. Wrocław scientists are working on a new device” Gazeta Wyborcza daily about Genomtec
Professor Tadeusz Dobosz and Miron Tokarski in an interview for Gazeta Wyborcza, Wrocław edition reveal the origins of Genomtec S.A. and explain ...
Genomtec starts pilot work with Amplus as part of the Pilot Maker programme
Genomtec’s technology has been chosen for a pilot implementation by the Pilot Maker programme experts, managed by TechBrainers in ...